Literature DB >> 19135984

ZIC1 is downregulated through promoter hypermethylation in gastric cancer.

Liang Jing Wang1, Hong Chuan Jin, Xian Wang, Emily K Y Lam, Jian Bin Zhang, Xin Liu, Francis K L Chan, Jian Min Si, Joseph J Y Sung.   

Abstract

As one of major epigenetic changes responsible for tumor suppressor gene inactivation in the development of cancer, promoter hypermethylation was proposed as a marker to define novel tumor suppressor genes. In the current study we identified ZIC1 (Zic family member 1, odd-paired Drosophila homolog) as a novel tumor suppressor gene silenced through promoter hypermethylation in gastric cancer, the second leading cause of cancer death worldwide. In all of gastric cancer cells lines examined, ZIC1 expression was downregulated and such downregulation was accompanied with the hypermethylation of ZIC1 promoter. Demethylation treatment with 5-aza-2'-deoxycytidine (Aza) reversed ZIC1 downregulation, highlighting the importance of promoter methylation to ZIC1 downregulation in gastric cancer cells. Notably, ZIC1 expression was significantly downregulated in primary gastric carcinoma tissues in comparison with non-tumor adjacent gastric tissues (p<0.01). Accordingly, promoter methylation of ZIC1 was frequently detected in primary gastric carcinoma tissues (94.6%, 35/37) but not normal gastric tissues, indicating that promoter hypermethylation mediated ZIC1 downregulation may play an important role in gastric carcinogenesis. Indeed, ectopic expression of ZIC1 led to the growth inhibition of gastric cancer cells through the induction of S-phase cell cycle arrest (p<0.01). Our results revealed ZIC1 as a novel candidate tumor suppressor gene downregulated through promoter hypermethylation in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19135984     DOI: 10.1016/j.bbrc.2008.12.180

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis.

Authors:  Liangjing Wang; Shujie Chen; Meng Xue; Jing Zhong; Xian Wang; Lihong Gan; Emily K Y Lam; Xin Liu; Jianbin Zhang; Tianhua Zhou; Jun Yu; Hongchuan Jin; Jianmin Si
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

2.  Klotho is silenced through promoter hypermethylation in gastric cancer.

Authors:  Liangjing Wang; Xian Wang; Xiaojia Wang; Pan Jie; Haiqi Lu; Shengjie Zhang; Xiaoying Lin; Emily Ky Lam; Yan Cui; Jun Yu; Hongchuan Jin
Journal:  Am J Cancer Res       Date:  2010-11-10       Impact factor: 6.166

3.  Virulence of infecting Helicobacter pylori strains and intensity of mononuclear cell infiltration are associated with levels of DNA hypermethylation in gastric mucosae.

Authors:  Barbara G Schneider; M Blanca Piazuelo; Liviu A Sicinschi; Robertino Mera; Dun-Fa Peng; Juan Carlos Roa; Judith Romero-Gallo; Alberto G Delgado; Thibaut de Sablet; Luis E Bravo; Keith T Wilson; Wael El-Rifai; Richard M Peek; Pelayo Correa
Journal:  Epigenetics       Date:  2013-08-22       Impact factor: 4.528

4.  A single factor induces neuronal differentiation to suppress glioma cell growth.

Authors:  Ji-Qiang Fu; Zhen Chen; Yong-Jia Hu; Zhao-Huan Fan; Zhen-Xing Guo; Jin-Ye Liang; Bo-Mi Ryu; Jian-Lin Ren; Xiu-Juan Shi; Jiao Li; Song Jia; Juan Wang; Xiao-Si Ke; Xin Ma; Xiao Tan; Ting Zhang; Xian-Zhen Chen; Chen Zhang
Journal:  CNS Neurosci Ther       Date:  2018-09-27       Impact factor: 5.243

Review 5.  Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.

Authors:  Jun Nakamura; Tomokazu Tanaka; Yoshihiko Kitajima; Hirokazu Noshiro; Kohji Miyazaki
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

6.  Role of ZIC1 methylation in hepatocellular carcinoma and its clinical significance.

Authors:  Yan-Ying Wang; Jian-Xin Jiang; Hong Ma; Jie Han; Zhi-Yang Sun; Zhong-Min Liu; Zeng-Guang Xu
Journal:  Tumour Biol       Date:  2014-04-30

Review 7.  Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.

Authors:  Keishi Yamashita; Shinichi Sakuramoto; Masahiko Watanabe
Journal:  Surg Today       Date:  2010-12-30       Impact factor: 2.549

8.  CHD5 is down-regulated through promoter hypermethylation in gastric cancer.

Authors:  Xian Wang; Kenneth K K Lau; Leo K Y So; Yun Wah Lam
Journal:  J Biomed Sci       Date:  2009-10-19       Impact factor: 8.410

9.  Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers.

Authors:  Rui-Lan Huang; Fei Gu; Nameer B Kirma; Jianhua Ruan; Chun-Liang Chen; Hui-Chen Wang; Yu-Ping Liao; Cheng-Chang Chang; Mu-Hsien Yu; Jay M Pilrose; Ian M Thompson; Hsuan-Cheng Huang; Tim Hui-Ming Huang; Hung-Cheng Lai; Kenneth P Nephew
Journal:  Epigenetics       Date:  2013-05-10       Impact factor: 4.528

10.  Clinicopathological significance of increased ZIC1 expression in human endometrial cancer.

Authors:  Xing Gu; Qin Liu; Ning Yang; Jian-Fang Shen; Xue-Gang Zhang; Fang Cao; Hou-Zhong Ding
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.